Polycyclo heterocyclic ring system containing ring nitrogen

Subclass of:

548 - Organic compounds -- part of the class 532-570 series

548000000 - ORGANIC COMPOUNDS (CLASS 532, SUBCLASS 1)

548000000 - HETEROCYCLIC CARBON COMPOUNDS CONTAINING A HETERO RING HAVING CHALCOGEN (I.E., OXYGEN, SULFUR, SELENIUM, OR TELLURIUM) OR NITROGEN AS THE ONLY RING HETERO ATOMS (Class 540, subclass 1)

548100000 - Hetero ring is five-membered having two or more ring hetero atoms of which at least one is nitrogen (e.g., selenazoles, etc.)

548146000 - 1,3-thiazoles (including hydrogenated)

Patent class list (only not empty are listed)

Deeper subclasses:

Class / Patent application number	Description	Number of patent applications / Date published
548181000	Polycyclo heterocyclic ring system containing ring nitrogen	8
20100324302	PROCESSES FOR MAKING EPOTHILONE COMPOUNDS AND ANALOGS - The present invention relates to processes for making epothilone compounds and analogs thereof, such as epi-epothilone A or epi-epothilone B, and aziridinyl-epothilone analogs.	12-23-2010
20110046388	Crystalline forms of thiazolidinedione compound and its manufacturing method - It is an object of the present invention to provide the crystalline form of a thiazolidinedione compound, which is effective as a pharmaceutical ingredient for manufacturing a peroxisome proliferator-activated receptor (PPAR) activator and an anticancer pharmaceutical composition. The present invention relates to a crystalline form of a hydrate of 5-(4-{[6-(4-amino-3,5-dimethylphenoxy)-1-methyl-1-H benzimidazol-2-yl]methoxy}benzyl)-1,3-thiazolidine-2,4-dione dihydrochloride represented by the following formula (I). [Formula 1]	02-24-2011
20110213158	Crystalline forms of thiazolidinedione compound and its manufacturing method - It is an object of the present invention to provide the crystalline form of a thiazolidinedione compound, which is effective as a pharmaceutical ingredient for manufacturing a peroxisome proliferator-activated receptor (PPAR) activator and an anticancer pharmaceutical composition. The present invention relates to a crystalline form of a hydrate of 5-(4-{[6-(4-amino-3,5-dimethylphenoxy)-1-methyl-1-H benzimidazol-2-yl]methoxy}benzyl)-1,3-thiazolidine-2,4-dione dihydrochloride represented by the following formula (I). [Formula 1]	09-01-2011
20120095236	PYRROLOPYRROLE DERIVATIVES, THEIR MANUFACTURE AND USE AS SEMICONDUCTORS - The present invention relates to compounds of the formula (I) wherein the substituents are as defined in claim	04-19-2012
20120178941	PROCESSES FOR MAKING EPOTHILONE COMPOUNDS AND ANALOGS - A process for making aziridinyl epothilone compounds according to formula G,	07-12-2012
20120238759	METHOD FOR MANUFACTURING A 6-SUBSTITUTED 1-METHYL-1H-BENZIMIDAZOLE DERIVATIVE AND AN INTERMEDIATE OF SAID METHOD - A method for manufacturing a 6-substituted 1-methyl-1H-benzimidazole derivative represented by the formula (IV)	09-20-2012
20130012719	Convenient Synthesis of Azolines to Azoles - Azolines are oxidized in the presence of a copper-containing catalyst to azoles in the presence of molecular oxygen. A synthetic scheme converting azolines azoles is also provided.	01-10-2013
20140256952	PROCESS FOR IXABEPILONE, AND INTERMEDIATES THEREOF - The present invention relates to a novel process of making ixabepilone, ixabepilone derivatives and analogues, and intermediates thereof.	09-11-2014